1)岩渕三哉,渡辺英伸,石原法子,他.消化管のカルチノイドと内分泌細胞癌の病理—その特徴と組織発生.臨消内科 5:1669-1681, 1990
2)岩渕三哉,西倉健,渡辺英伸.胃と大腸の早期内分泌細胞癌—その特徴と発生.消内視鏡 7:275-284, 1995
3)岩渕三哉,草間文子,渡辺徹,他.胃の内分泌細胞癌の特性.病理と臨23:966-973, 2005
4)岩渕三哉.内分泌細胞腫瘍.病理と臨 38:1018-1025, 2020
5)日本胃癌学会(編).胃癌取扱い規約,第15版,金原出版,2017
6)WHO Classification of Tumours Editorial Board(eds). WHO Classification of Tumours, Digestive System Tumours, 5th ed. IARC press, Lyon, 2019
7)Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and gastric neuroendocrine carcinoma:a clinicopathologic study. Gastroenterology 104:994-1006, 1993
8)Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas:pathogenesis, pathology, and behavior. World J Surg 20:168-172, 1996
9)Bosman FT, Carneiro F, Hruban RH, et al(eds). WHO Classification of Tumours of the Digestive System, 4th ed., IARC press, Lyon, 2010
10)Matsusaka T, Watanabe H, Enjoji M. Oat-cell carcinoma of the stomach. Fukuoka Igaku Zasshi 67:65-73, 1976
11)Abraham SC, Carney JA, Ooi A, et al. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids:a new disorder. Am J Surg Pathol 29:969-975, 2005
12)Nakata K, Aishima S, Ichimiya H, et al. Unusual multiple gastric carcinoids with hypergastrinemia:report of a case. Surg Today 40:267-271, 2010
13)Ishioka M, Hirasawa T, Kawachi H, et al. Enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction. Gastrointest Endosc 90:841-845, 2019
14)Ooi A, Ota M, Katsuda S, et al. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr Pathol 6:229-237, 1995
15)下田忠和,佐野量造.興味ある胃病変の病理解説(5).胃と腸 10:608, 1975
16)二村聡.消化管リンパ腫の病理診断—基本的事項を中心に.胃と腸 49:574-580, 2014